S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants
S&P 500   5,069.76
DOW   38,949.02
QQQ   435.27
FedEx ends naming rights agreement for the Washington Commanders stadium long known as FedEx Field
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Are NFTs Back? Why NFTs Will Make a Comeback in 2024
US economy grew solid 3.2% in fourth quarter, a slight downgrade from government's initial estimate
Game-Changing Cancer Tech Nears FDA Completion (Ad)
Dubai's sky-high aspirations find a new outlet as it hosts a jet suit race for 'Iron Man' pilots
Apple Cancels Its 10-Year Electric Car Project, Moves Some Employees to AI Division
Detecting Cancer in Mere Seconds: Early Investment Opportunity (Ad)
Leaders, Here Are 4 Ways You're Inadvertently Destroying Trust in the Workplace (and What to Do Instead)
Wendy's says it has no plans to raise prices during the busiest times at its restaurants

Nektar Therapeutics (NKTR) Institutional Ownership

$0.72
-0.03 (-4.00%)
(As of 02/28/2024 ET)

Institutional Ownership Changes (13F Filings) for Nektar Therapeutics (NASDAQ:NKTR)

Current
Institutional Ownership
Percentage
82.20%
Number of
Institutional Buyers
(last 12 months)
51
Total
Institutional Inflows
(last 12 months)
$49.83 M
Number of
Institutional Sellers
(last 12 months)
33
Total
Institutional Outflows
(last 12 months)
$32.23 M
Get NKTR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Nektar Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

NKTR Institutional Buying and Selling by Quarter


Nektar Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/16/2024GSA Capital Partners LLP5,255,790$2.97M0.2%+185.5%2.755%
2/16/2024Public Employees Retirement System of Ohio274,924$0.16M0.0%-11.4%0.144%
2/15/2024Barclays PLC567,902$0.32M0.0%+147.1%0.298%
2/15/2024Vanguard Group Inc.12,042,873$6.80M0.0%-0.2%6.313%
2/14/2024Balyasny Asset Management L.P.1,100,000$0.62M0.0%-17.5%0.577%
2/13/2024Northern Trust Corp426,119$0.24M0.0%+18.4%0.223%
2/13/2024Goldman Sachs Group Inc.863,869$0.49M0.0%-15.8%0.453%
2/9/2024Primecap Management Co. CA7,001,747$3.96M0.0%-2.7%3.670%
2/7/2024Dimensional Fund Advisors LP546,665$0.31M0.0%-7.0%0.287%
2/7/2024Monaco Asset Management SAM5,973,387$3.38M1.0%+24.2%3.131%
2/6/2024Charles Schwab Investment Management Inc.1,093,926$0.62M0.0%+1.9%0.573%
2/5/2024Russell Investments Group Ltd.112,769$64K0.0%-28.9%0.059%
2/2/2024Marquette Asset Management LLC186,163$0.11M0.0%+25.5%0.098%
2/2/2024Acuitas Investments LLC911,204$0.52M0.3%+26.3%0.478%
1/30/2024Mackenzie Financial Corp75,034$42K0.0%N/A0.039%
1/17/2024Assenagon Asset Management S.A.2,466,267$1.39M0.0%-13.0%1.293%
1/12/2024SG Americas Securities LLC101,687$57K0.0%+30.6%0.053%
12/6/2023Citigroup Inc.77,978$46K0.0%+1,993.9%0.041%
11/17/2023Diversified Trust Co60,211$36K0.0%N/A0.032%
11/17/2023Jacobs Levy Equity Management Inc.4,904,745$2.92M0.0%+0.7%2.571%
11/15/2023RA Capital Management L.P.18,700,000$11.14M0.2%N/A9.802%
11/15/2023GSA Capital Partners LLP1,841,078$1.10M0.1%+931.5%0.965%
11/15/2023AQR Capital Management LLC3,666,264$2.18M0.0%+29.9%1.922%
11/14/2023Schonfeld Strategic Advisors LLC119,200$71K0.0%+272.5%0.062%
11/14/2023Lynx1 Capital Management LP1,766,815$1.05M0.7%N/A0.926%
11/14/2023Qube Research & Technologies Ltd57,528$34K0.0%-84.8%0.030%
11/14/2023Primecap Management Co. CA7,197,983$4.29M0.0%-11.7%3.773%
11/13/2023Connor Clark & Lunn Investment Management Ltd.491,975$0.29M0.0%-22.5%0.258%
11/13/2023Acadian Asset Management LLC7,626,388$4.54M0.0%+73.5%3.998%
11/13/2023Invesco Ltd.359,347$0.21M0.0%-93.5%0.188%
11/13/2023FMR LLC76,635$46K0.0%-76.6%0.040%
11/9/2023Citigroup Inc.77,978$46K0.0%+1,993.9%0.041%
11/9/2023UBS Group AG48,897$29K0.0%+396.1%0.026%
11/8/2023Charles Schwab Investment Management Inc.1,074,049$0.64M0.0%+7.4%0.565%
11/7/2023Monaco Asset Management SAM4,809,601$2.87M0.8%-48.1%2.530%
11/7/2023CM Management LLC800,000$0.48M0.5%+6.7%0.421%
11/7/2023Barclays PLC229,841$0.14M0.0%+300.9%0.121%
11/6/2023Assenagon Asset Management S.A.2,835,463$1.69M0.0%+36.3%1.491%
10/30/2023First Citizens Bank & Trust Co.51,311$31K0.0%-47.7%0.027%
10/24/2023Bank of New York Mellon Corp88,259$53K0.0%-30.1%0.046%
10/20/2023Harbor Capital Advisors Inc.49,769$30K0.0%-39.9%0.026%
10/13/2023SG Americas Securities LLC77,858$46K0.0%-27.4%0.041%
9/21/2023Barclays PLC57,332$33K0.0%-62.5%0.030%
8/15/2023Public Employees Retirement System of Ohio311,124$0.18M0.0%+66.1%0.164%
8/15/2023First Citizens Bank & Trust Co.98,129$56K0.0%N/A0.052%
8/15/2023Y Intercept Hong Kong Ltd312,003$0.18M0.0%N/A0.164%
8/15/2023Goldman Sachs Group Inc.1,302,369$0.75M0.0%+23.8%0.685%
8/15/2023Point72 Middle East FZE137,149$79K0.0%N/A0.072%
8/14/2023State Street Corp725,937$0.42M0.0%-89.6%0.382%
8/14/2023Deep Track Capital LP17,973,464$10.34M0.5%+931.0%9.454%
8/11/2023Renaissance Technologies LLC4,091,681$2.35M0.0%+36.2%2.162%
8/11/2023BlackRock Inc.8,604,322$4.95M0.0%-75.8%4.547%
8/11/2023Geode Capital Management LLC1,895,974$1.09M0.0%-46.1%1.002%
8/11/2023Northern Trust Corp365,853$0.21M0.0%-79.5%0.193%
8/10/2023Charles Schwab Investment Management Inc.1,000,032$0.58M0.0%-16.9%0.528%
8/9/2023Dimensional Fund Advisors LP809,049$0.47M0.0%-61.2%0.428%
8/9/2023BNP Paribas Arbitrage SNC162,559$94K0.0%+11.8%0.086%
8/8/2023Monaco Asset Management SAM9,260,717$5.33M1.5%N/A4.894%
8/7/2023Principal Financial Group Inc.53,034$31K0.0%-95.4%0.028%
8/7/2023Acadian Asset Management LLC4,396,020$2.53M0.0%+597.5%2.323%
8/4/2023Envestnet Asset Management Inc.63,411$36K0.0%N/A0.034%
8/4/2023CM Management LLC750,000$0.43M0.4%+87.5%0.396%
8/3/2023Barclays PLC57,332$33K0.0%-62.5%0.030%
8/3/2023Bank of New York Mellon Corp126,197$73K0.0%-92.1%0.067%
7/31/2023Moloney Securities Asset Management LLC355,105$0.20M0.0%N/A0.188%
7/31/2023Inspire Investing LLC551,556$0.32M0.0%+40.1%0.291%
7/28/2023Marquette Asset Management LLC148,378$85K0.0%N/A0.078%
7/25/2023Assenagon Asset Management S.A.2,080,518$1.20M0.0%+213.6%1.099%
7/11/2023Harbor Capital Advisors Inc.82,798$48K0.0%N/A0.044%
7/10/2023SG Americas Securities LLC107,236$62K0.0%-39.4%0.057%
5/22/2023Ameriprise Financial Inc.994,370$0.70M0.0%+11.4%0.525%
5/18/2023JPMorgan Chase & Co.232,486$0.16M0.0%+21.7%0.123%
5/18/2023New York State Common Retirement Fund81,400$57K0.0%-29.4%0.043%
5/16/2023Jane Street Group LLC521,707$0.37M0.0%+242.9%0.276%
5/16/2023State Street Corp6,981,089$4.91M0.0%-4.8%3.689%
5/16/2023Squarepoint Ops LLC680,514$0.48M0.0%+1,370.6%0.360%
5/16/2023Geode Capital Management LLC3,518,076$2.47M0.0%+2.2%1.859%
5/16/2023Graham Capital Management L.P.614,897$0.43M0.0%+42.4%0.325%
5/16/2023AQR Capital Management LLC2,738,029$1.71M0.0%+518.3%1.447%
5/15/2023Cubist Systematic Strategies LLC61,428$43K0.0%-83.2%0.032%
5/15/2023Two Sigma Advisers LP2,544,342$1.79M0.0%+376.8%1.345%
5/15/2023Two Sigma Investments LP2,026,450$1.42M0.0%+409.5%1.071%
5/15/2023Deutsche Bank AG129,708$91K0.0%+33.4%0.069%
5/15/2023Price T Rowe Associates Inc. MD287,670$0.20M0.0%+11.6%0.152%
5/12/2023Renaissance Technologies LLC3,003,696$2.11M0.0%+2,464.8%1.587%
5/12/2023Great West Life Assurance Co. Can183,836$0.13M0.0%-24.4%0.097%
5/12/2023BlackRock Inc.35,558,958$24.99M0.0%-1.0%18.790%
5/12/2023BNP Paribas Arbitrage SNC145,395$0.10M0.0%+148.1%0.077%
5/12/2023Bank of America Corp DE257,579$0.18M0.0%+30.6%0.136%
5/12/2023HRT Financial LP379,117$0.27M0.0%-9.8%0.200%
5/12/2023Public Sector Pension Investment Board330,568$0.23M0.0%-4.0%0.175%
5/12/2023Dimensional Fund Advisors LP2,084,461$1.47M0.0%-18.3%1.101%
5/12/2023Charles Schwab Investment Management Inc.1,203,469$0.85M0.0%-12.6%0.636%
5/11/2023Acadian Asset Management LLC630,249$0.44M0.0%+2,606.6%0.333%
5/11/2023Rhumbline Advisers617,626$0.43M0.0%+7.1%0.326%
5/11/2023Citigroup Inc.87,017$61K0.0%-32.9%0.046%
5/10/2023Pictet Asset Management SA3,720,679$2.62M0.0%+221.9%1.966%
5/10/2023Swiss National Bank405,700$0.29M0.0%-10.3%0.214%
5/10/2023Connor Clark & Lunn Investment Management Ltd.448,227$0.32M0.0%+177.8%0.237%
5/9/2023Principal Financial Group Inc.1,160,930$0.82M0.0%-1.4%0.613%
(Data available from 1/1/2016 forward)













NKTR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of NKTR shares?

During the previous two years, 191 institutional investors and hedge funds held shares of Nektar Therapeutics. The most heavily invested institutionals were Maverick Capital Ltd. ($25.83M), First Trust Advisors LP ($23.67M), RA Capital Management L.P. ($11.14M), Deep Track Capital LP ($10.34M), Vanguard Group Inc. ($6.80M), BlackRock Inc. ($4.95M), and Acadian Asset Management LLC ($4.54M).Learn more on NKTR's institutional investors.

What percentage of Nektar Therapeutics stock is owned by institutional investors?

82.20% of Nektar Therapeutics stock is owned by institutional investors. Learn more on NKTR's institutional investor holdings.

Which institutional investors have been buying Nektar Therapeutics stock?

Of the 148 institutional investors that purchased Nektar Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: RA Capital Management L.P. ($18.70M), Deep Track Capital LP ($16.23M), Monaco Asset Management SAM ($10.42M), Acadian Asset Management LLC ($7.60M), GSA Capital Partners LLP ($5.66M), Renaissance Technologies LLC ($4.09M), and AQR Capital Management LLC ($3.68M).

How much institutional buying is happening at Nektar Therapeutics?

Institutional investors have bought a total of 114,409,911 shares in the last 24 months. This purchase volume represents approximately $168.41M in transactions.

Which Nektar Therapeutics major shareholders have been selling company stock?

Of the 103 institutional investors that sold Nektar Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: BlackRock Inc. ($27.88M), State Street Corp ($7.48M), Invesco Ltd. ($5.18M), Monaco Asset Management SAM ($4.45M), Dimensional Fund Advisors LP ($2.22M), Primecap Management Co. CA ($2.14M), and Alliancebernstein L.P. ($1.86M).

How much institutional selling is happening at Nektar Therapeutics?

Institutional investors have sold a total of 69,044,637 shares in the last 24 months. This volume of shares sold represents approximately $81.80M in transactions.


This page (NASDAQ:NKTR) was last updated on 2/29/2024 by MarketBeat.com Staff